Further, targeting GSPT1 with the small molecule CC-90009 exhibitedstrong synergistic effects when combined with FLT3 inhibitors in the FLT3-ITDcell lines and primary AML patient samples. Here, FLT3 is linked to acute myeloid leukemia.